Clinical Trial Update: Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of IMG-7289, an LSD1 inhibitor, in essential thrombocythemia. The study is active but not recruiting, with results posted on 2025-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia

Drugs mentioned

• IMG-7289 (LSD1 inhibitor)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Thrombocythemia, Essential | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-20